MKP7/DUSP16在癌症中的调控作用
Shiqi Chen1, Maryam Mohammed Abbas Karekad2, Jiaxi Yan1
1The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
Medical oncology (Northwood, London, England)
|November 30, 2025
概括
线素激活蛋白激酶酸酶 (MKPs),特别是MKP7/DUSP16,与癌症进展和药物耐药性有关. 本综述探讨了MKP7/DUSP16如何通过MAPK和亡途径促进瘤生长.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 生物化学 生物化学
背景情况:
- 线素激活蛋白激酶酸酶 (MKPs) 或双特异性酸酶 (DUSPs) 是MAPK信号通路的关键调节者.
- MKP7/DUSP16特别针对p38和JNK MAPKs,对JNK有显著的抑制作用.
- MKP7/DUSP16的失调越来越多地与癌症进展和治疗耐药性有关,强调其作为预后生物标志物的潜力.
研究的目的:
- 审查和总结MKP7/DUSP16促进瘤增殖的拟议机制.
- 巩固目前对MKP7/DUSP16在癌细胞调节中的作用的理解.
主要方法:
- 对MKP7/DUSP16和癌症现有研究的文献综述.
- 对MAPK和亡途径中拟议的调节作用的分析.
- 综合证据表明MKP7/DUSP16参与癌细胞增殖.
主要成果:
- 建议MKP7/DUSP16通过调节MAPK通路来促进癌症的进展.
- 有证据表明MKP7/DUSP16影响线粒体亡途径.
- 酸酶也可能通过与免疫细胞相互作用,促进癌细胞的增殖.
结论:
- 通过多种细胞机制,MKP7/DUSP16似乎发挥了促瘤的作用.
- 进一步的研究对于阐明MKP7/DUSP16在各种癌症环境中的精确调节功能至关重要.
- 了解这些机制可能会导致针对MKP7/DUSP16在癌症治疗中的新型治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K


